Lexaria Bioscience Corporation is a biotech company developing a drug delivery technology, DehydraTECH, that improves the way active pharmaceutical ingredients enter the bloodstream. Dehydra being evaluated for orally administered anti-viral drugs and non-steroidal anti-inflammatory drugs. Lexaria Bioscience was incorporated in 2004 and is headquartered in Kelowna, British Columbia, Canada.
Name / Ticker | Price | Zen Rating |
---|---|---|
$3.07 | A | |
$8.24 | A | |
$24.29 | A |